Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, Anhui Shuanghe Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for the compound potassium hydrogen phosphate injection issued by the State Drug Administration. Compound potassium hydrogen phosphate injection as a phosphorus supplement: 1. Used to correct hypophosphatemia in adults and children when oral or enteral nutrition is impossible, inadequate, or contraindicated. 2. Use parenteral nutrition for adults and children when oral or enteral nutrition cannot be performed, is insufficient, or is contraindicated.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.